Published in Blood Weekly, March 11th, 1996
Enrollment began in February 1995 at two centers: Minas Gerais and Rio de Janeiro.
The trial is intended to evaluate different dose and vaccination schedules. Details of the trial were announced at the Eighth Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS (NCVDG), held February 11-15,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.